GlassScriptPhysician profile
David A Jansen
NPI 1316042856
$12,185.31
in general payments reported to CMS, 2019-2025
27 companies · $1,743 in 2025
The $1,743 reported for 2025 was more than what 81% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,295 · 2020: $607 · 2021: $561 · 2022: $1,350 · 2023: $1,817 · 2024: $1,811 · 2025: $1,743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,371.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $4,346.73 | 2019-2022 | |
| Abbvie INC. | $2,435.14 | 2023-2025 | |
| Mentor Worldwide LLC | $1,599.23 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Baxter Healthcare | $376.32 | 2019-2025 | Artiss |
| Smith+Nephew, INC. | $327.75 | 2019-2025 | Pico 14, Renasys Touch |
| Tela Bio, INC. | $314.66 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Organogenesis INC. | $299.42 | 2024-2025 | Puraply Wound Matrix |
| Integra Lifesciences Corporation | $292.71 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $262.30 | 2022 | |
| Acera Surgical, INC. | $261.51 | 2022-2025 | Restrata Wound Matrix |
| Becton, Dickinson and Company | $200.91 | 2023-2025 | Phasix Mesh |
| Polynovo North America LLC | $198.85 | 2019-2024 | Novosorb Btm |
| Musculoskeletal Transplant Foundation INC. | $191.73 | 2019-2021 | |
| Merz North America, INC. | $188.08 | 2019-2023 | Xeomin |
| Galderma Laboratories, L.P. | $163.03 | 2020-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $149.89 | 2025 | Cohealyx, Recell, Permeaderm |
| Kerecis Limited | $139.29 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Osiris Therapeutics INC. | $120.55 | 2019 | |
| Kls-Martin L.P. | $114.70 | 2020 | |
| Axogen | $51.37 | 2023-2025 | Avance Nerve Graft |
| Sientra, INC. | $34.80 | 2021 | |
| Covidien LP | $32.48 | 2019 | |
| Convatec INC. | $23.91 | 2021 | |
| Heron Therapeutics, INC. | $22.75 | 2024 | Zynrelef |
| Kowa Pharmaceuticals America, INC. | $16.35 | 2023 | Seglentis |
| Vertex Pharmaceuticals Incorporated | $14.59 | 2025 | |
| Elekta, INC. | $6.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Jansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.